Comparison of the effects of single predonine and predonine-iguratimod therapy on the old elderly onset arthritis.randomized controlled trial.

Comparison of the effects of single predonine and predonine-iguratimod therapy on the old elderly onset arthritis.randomized controlled trial. - The effects of iguratimod therapy on the elderly onset arthritis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022036

Enrollment

Registered

2016-08-01

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly onset arthritis

Interventions

Predonine single group Predonine treatment protocol starting with 15 mg/day for 4weeks and,12.5 mg/day a for 4 weeks,10 mg/day for 4-6 weeks, and tapering for 1mg/4-8 weeks until completion of treatm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Arthritis patient diagnosis to after 50 years old. Patient not have a poor-prognosis gene (rheumatoid factor,antiCCP antibody, Sore bone in X-rays,high disease activity).

Exclusion criteria

Exclusion criteria: Predonine-iguratimode intolerable patients. Patients not treated with predonine-iguratimode and such as an immunosuppressive drug or the biologicals within one month. Pregnant or possibly pregnant patients.

Design outcomes

Primary

Measure	Time frame
Revival rate (during two years from start of therapy)	—

Secondary

Measure	Time frame
dose of steroid(mg/day) (after 6.12.18.24 month from start of therapy)	—

Countries

Japan

Contacts

Public ContactShinkai Ri

Kinki University Facalty of Medicine Division of Hematology and Rheumatology

jinhai@med.kindai.ac.jp0723660221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026